There are currently at least 157 studies, with 108 being peer-reviewed (as of April 1, 2022), showing that Ivermectin is highly effective in treating COVID-19 in early stages, late stages, and as prophylaxis (preventative measure).
View the data and studies here and here. Also watch Congressional testimony from Dr. Pierre Kory about Ivermectin.
Slovakia becomes first EU country to approve Ivermectin as prophylaxis and treatment for COVID-19 patients (January 28, 2021)
Dr. William C. Campbell and Dr. Satoshi Omura win the 2015 Nobel Prize in Physiology and Medicine for discovering Ivermectin.
According to the Barcelona Institute of Global Health:
[Ivermectin] is used to treat millions of people at risk of contracting devastating diseases, such as onchocerciasis and lymphatic filariasis, and also plays an important role in the control of intestinal helminth infections. Because of its excellent safety profile and broad spectrum of activity, ivermectin is catalogued by the World Health Organisation as an essential medicine and is regarded by many as a “magic bullet” for global health.
The article concludes, “The global community must act to ensure that essential medicines are affordable, accessible and available to those who need them, irrespective of what disease they may have or where they were born.”
Watch “A Case For Ivermectin” by The S.A.Q. Project. It expands further on Dr. Kory’s testimony with more facts and news surrounding Ivermectin suppression.
New York Judge Saves 80-Year-Old COVID-19 Patient By Ordering Hospital To Give Her Ivermectin (January 18, 2021)
Antiparasitic drug Ivermectin kills coronavirus in 48 hours (April 6, 2020)